Acasti Pharma Inc (ACST)
2.90
-0.03
(-0.97%)
USD |
NASDAQ |
Apr 26, 16:00
2.92
+0.02
(+0.69%)
Pre-Market: 20:00
Acasti Pharma Total Return Level: 2.90 for April 26, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 26, 2024 | 2.90 |
April 25, 2024 | 2.928 |
April 24, 2024 | 2.90 |
April 23, 2024 | 2.88 |
April 22, 2024 | 2.85 |
April 19, 2024 | 2.87 |
April 18, 2024 | 3.07 |
April 17, 2024 | 3.190 |
April 16, 2024 | 3.35 |
April 15, 2024 | 3.36 |
April 12, 2024 | 3.405 |
April 11, 2024 | 3.40 |
April 10, 2024 | 3.40 |
April 09, 2024 | 3.40 |
April 08, 2024 | 3.40 |
April 05, 2024 | 3.40 |
April 04, 2024 | 3.40 |
April 03, 2024 | 3.38 |
April 02, 2024 | 3.43 |
April 01, 2024 | 3.45 |
March 28, 2024 | 3.425 |
March 27, 2024 | 3.40 |
March 26, 2024 | 3.40 |
March 25, 2024 | 3.41 |
March 22, 2024 | 3.40 |
Date | Value |
---|---|
March 21, 2024 | 3.40 |
March 20, 2024 | 3.40 |
March 19, 2024 | 3.40 |
March 18, 2024 | 3.40 |
March 15, 2024 | 3.38 |
March 14, 2024 | 3.41 |
March 13, 2024 | 3.40 |
March 12, 2024 | 3.43 |
March 11, 2024 | 3.35 |
March 08, 2024 | 3.40 |
March 07, 2024 | 3.40 |
March 06, 2024 | 3.41 |
March 05, 2024 | 3.405 |
March 04, 2024 | 3.44 |
March 01, 2024 | 3.435 |
February 29, 2024 | 3.34 |
February 28, 2024 | 3.40 |
February 27, 2024 | 3.33 |
February 26, 2024 | 3.37 |
February 23, 2024 | 3.35 |
February 22, 2024 | 3.365 |
February 21, 2024 | 3.34 |
February 20, 2024 | 3.11 |
February 16, 2024 | 3.30 |
February 15, 2024 | 3.06 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.77
Minimum
Sep 22 2023
139.20
Maximum
Jul 30 2019
22.51
Average
9.597
Median
Oct 01 2020
Total Return Level Benchmarks
Aurinia Pharmaceuticals Inc | 4.91 |
Edesa Biotech Inc | 4.420 |
Lexaria Bioscience Corp | 2.35 |
Xenon Pharmaceuticals Inc | 40.50 |
ESSA Pharma Inc | 6.08 |